| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells
|
Mahgoub, Thamir M.
|
|
|
93 |
5 |
p. 427-437
|
artikel
|
| 2 |
Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells
|
Chernov, Alexandr N.
|
|
|
93 |
5 |
p. 455-469
|
artikel
|
| 3 |
Inhibition of proteinase-activated receptor 2 (PAR2) decreased the malignant progression of lung cancer cells and increased the sensitivity to chemotherapy
|
Huo, Hongjie
|
|
|
93 |
5 |
p. 397-410
|
artikel
|
| 4 |
Midostaurin drug interaction profile: a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants
|
Sechaud, Romain
|
|
|
93 |
5 |
p. 439-453
|
artikel
|
| 5 |
Pharmacokinetic drug–drug interaction between olaparib and apixaban: a case report
|
Berge, M.
|
|
|
93 |
5 |
p. 519-521
|
artikel
|
| 6 |
Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy study
|
Fan, Bin
|
|
|
93 |
5 |
p. 471-479
|
artikel
|
| 7 |
Pharmacology and pharmacokinetics of tazemetostat
|
Orleni, Marco
|
|
|
93 |
5 |
p. 509-517
|
artikel
|
| 8 |
Retraction Note: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
|
Oya, Mototsugu
|
|
|
93 |
5 |
p. 523
|
artikel
|
| 9 |
Ruthenium–dihydroartemisinin complex: a promising new compound for colon cancer prevention via G1 cell cycle arrest, apoptotic induction, and adaptive immune regulation
|
Wang, Chong-Zhi
|
|
|
93 |
5 |
p. 411-425
|
artikel
|
| 10 |
The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations
|
Ma, Xiaoya
|
|
|
93 |
5 |
p. 481-496
|
artikel
|
| 11 |
Visceral obesity and sarcopenia as predictors of efficacy and hematological toxicity in patients with metastatic breast cancer treated with CDK 4/6 inhibitors
|
Yücel, Kadriye Bir
|
|
|
93 |
5 |
p. 497-507
|
artikel
|
Tijdschrift beschrijving